Companies: 10,795·Total market cap: $144.5T
Diagnamed Holdings Corp.

Diagnamed Holdings Corp.

DMED.CNCNQHealthcare● Active
$0.05
+$0.00(+0.00%)
Market Cap$4595800
P/E Ratio
52W High$0.25
52W Low$0.03
Overview

Diagnamed Holdings Corp. (DMED.CN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

DMED.CN · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2023
EPS Actual
$0.00
Revenue
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Dec 31, 2023
After Market Close
DMED.CN reports quarterly as a CNQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Next earnings date not yet announced.

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q4 FY2023
Dec 31, 2023
EPS Actual
$0.00
EPS Est.
EPS Surpr.
Revenue
Q1 FY2023
Mar 31, 2023
EPS Actual
-$0.01
EPS Est.
EPS Surpr.
Revenue
Q4 FY2022
Dec 31, 2022
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q1 FY2022
Mar 31, 2022
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.00
EPS Est.
EPS Surpr.
Revenue
No analyst estimates available for DMED.CN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q4 FY2023+16.67%
Report Date
Dec 31, 2023
EPS Beat/Miss
Price Before
$0.03
Price After
$0.04
Q1 FY2023+11.11%
Report Date
Mar 31, 2023
EPS Beat/Miss
Price Before
$0.05
Price After
$0.05
Q4 FY2022+14.29%
Report Date
Dec 31, 2022
EPS Beat/Miss
Price Before
$0.04
Price After
$0.04
Q1 FY2022
Report Date
Mar 31, 2022
EPS Beat/Miss
Price Before
Price After
$0.06
Q4 FY2021
Report Date
Dec 31, 2021
EPS Beat/Miss
Price Before
Price After
$0.06
Beat Rate0 / 5 quarters
Largest Move+16.67% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: DMED.CN ends December

Diagnamed Holdings Corp. (DMED.CN) most recently reported earnings on December 31, 2023 for Q4 FY2023, posting EPS of $0.00 (in line with the analyst consensus of —).

Each quarter, investors track DMED.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. DMED.CN revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
DMED.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Frequently asked questions

DMED.CN earnings · 4 questions

Diagnamed Holdings Corp.'s next earnings report is expected around TBD. DMED.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; DMED.CN historically reports after market close (AMC).

DMED.CN earnings datewhen is DMED.CN earningsDMED.CN next earnings datewhen does DMED.CN report earningsDMED.CN earnings calendar

Source: FMP · Diagnamed Holdings Corp. SEC filings · US GAAP · Diagnamed Holdings Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026